Loading...
XCNQ
MRMD
Market cap26mUSD
Jun 18, Last price  
0.10CAD
1D
0.00%
1Q
-9.52%
IPO
-89.44%
Name

MariMed Inc

Chart & Performance

D1W1MN
XCNQ:MRMD chart
P/E
P/S
0.17
EPS
Div Yield, %
Shrs. gr., 5y
12.68%
Rev. gr., 5y
28.21%
Revenues
158m
+6.30%
125,60778590488,3841,270,1763,564,1206,067,85311,851,91545,604,64550,895,151121,464,158134,010,000148,598,000157,964,000
Net income
-12m
L-24.12%
-377,410-809,540-535,607-7,219,541-1,215,333-198,852-1,194,083-13,604,068-66,518,0852,143,9897,225,00013,468,000-16,030,999-12,164,000
CFO
7m
-14.22%
-181,267-127,465-10,653-692,537-392,881-197,9321,277,075-2,907,857-24,138,3173,380,30335,854,8377,311,0007,910,0006,785,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MariMed Inc. is a key player in the cannabis industry, involved in the cultivation, production, and distribution of both medicinal and adult-use cannabis products across the United States and internationally. The company's diverse brand portfolio includes Nature's Heritage for cannabis genetics, flowers, and concentrates, while Kalm Fusion offers cannabis-infused chewable tablets and powdered drink mixes. Its edibles segment features natural fruit chews under the Betty's Eddies brand and a variety of baked goods like brownies and cookies from Bubby's Baked. Additionally, MariMed develops cannabidiol (CBD) formulations under the Florance brand. The company further expands its operations by licensing its proprietary brands and product formulations, and by leasing cannabis-specific facilities. MariMed Inc. was founded in 2011 and maintains its headquarters in Norwood, Massachusetts.
IPO date
May 04, 2012
Employees
592
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT